ArticleDrug safety2020

Onapristone Extended Release: Safety Evaluation from Phase I-II Studies with an Emphasis on Hepatotoxicity.

James H Lewis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.